RenovoRx (RNXT) Competitors $1.20 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.22 +0.02 (+1.25%) As of 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNXT vs. CRBU, ENGN, VYGR, CYBN, CTMX, SXTC, DERM, LIMN, ACRS, and ENTAShould you be buying RenovoRx stock or one of its competitors? The main competitors of RenovoRx include Caribou Biosciences (CRBU), enGene (ENGN), Voyager Therapeutics (VYGR), Cybin (CYBN), CytomX Therapeutics (CTMX), China SXT Pharmaceuticals (SXTC), Journey Medical (DERM), Liminatus Pharma (LIMN), Aclaris Therapeutics (ACRS), and Enanta Pharmaceuticals (ENTA). These companies are all part of the "pharmaceutical products" industry. RenovoRx vs. Its Competitors Caribou Biosciences enGene Voyager Therapeutics Cybin CytomX Therapeutics China SXT Pharmaceuticals Journey Medical Liminatus Pharma Aclaris Therapeutics Enanta Pharmaceuticals RenovoRx (NASDAQ:RNXT) and Caribou Biosciences (NASDAQ:CRBU) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings. Which has preferable earnings and valuation, RNXT or CRBU? RenovoRx has higher earnings, but lower revenue than Caribou Biosciences. RenovoRx is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRenovoRx$40K1,097.10-$8.81M-$0.40-3.00Caribou Biosciences$9.99M16.85-$149.10M-$1.62-1.12 Is RNXT or CRBU more profitable? RenovoRx has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,490.84%. Caribou Biosciences' return on equity of -55.70% beat RenovoRx's return on equity.Company Net Margins Return on Equity Return on Assets RenovoRxN/A -119.58% -88.01% Caribou Biosciences -1,490.84%-55.70%-45.35% Do analysts prefer RNXT or CRBU? RenovoRx presently has a consensus price target of $7.25, suggesting a potential upside of 504.17%. Caribou Biosciences has a consensus price target of $6.67, suggesting a potential upside of 268.32%. Given RenovoRx's higher probable upside, research analysts clearly believe RenovoRx is more favorable than Caribou Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RenovoRx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Caribou Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in RNXT or CRBU? 3.1% of RenovoRx shares are owned by institutional investors. Comparatively, 77.5% of Caribou Biosciences shares are owned by institutional investors. 9.1% of RenovoRx shares are owned by company insiders. Comparatively, 8.3% of Caribou Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, RNXT or CRBU? RenovoRx has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, Caribou Biosciences has a beta of 2.55, suggesting that its stock price is 155% more volatile than the S&P 500. Does the media favor RNXT or CRBU? In the previous week, RenovoRx had 2 more articles in the media than Caribou Biosciences. MarketBeat recorded 2 mentions for RenovoRx and 0 mentions for Caribou Biosciences. Caribou Biosciences' average media sentiment score of 0.00 beat RenovoRx's score of -0.17 indicating that Caribou Biosciences is being referred to more favorably in the news media. Company Overall Sentiment RenovoRx Neutral Caribou Biosciences Neutral SummaryCaribou Biosciences beats RenovoRx on 8 of the 15 factors compared between the two stocks. Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RNXT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RNXT vs. The Competition Export to ExcelMetricRenovoRxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.89M$2.98B$5.48B$9.58BDividend YieldN/A2.47%4.00%4.17%P/E Ratio-3.009.0422.8424.86Price / Sales1,097.10302.83443.2295.40Price / CashN/A41.8335.9458.58Price / Book6.327.238.105.59Net Income-$8.81M-$54.43M$3.26B$265.48M7 Day Performance-3.23%-0.91%-0.09%-0.41%1 Month Performance-9.09%8.53%4.19%1.39%1 Year Performance7.62%13.40%29.38%24.69% RenovoRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RNXTRenovoRx2.5125 of 5 stars$1.20flat$7.25+504.2%+5.3%$43.89M$40K-3.006News CoverageUpcoming EarningsGap UpCRBUCaribou Biosciences2.4525 of 5 stars$1.94-15.5%$8.50+339.3%-3.8%$180.51M$9.99M-1.20100ENGNenGene3.3009 of 5 stars$3.51-3.6%$23.29+563.4%-49.9%$179.36MN/A-2.1331VYGRVoyager Therapeutics3.9179 of 5 stars$3.23-1.4%$13.39+315.2%-58.5%$179.03M$80M-2.22100News CoverageAnalyst ForecastCYBNCybin2.8516 of 5 stars$7.60-1.9%$85.00+1,019.2%N/A$178.81MN/A-1.7350Positive NewsCTMXCytomX Therapeutics3.999 of 5 stars$2.20-7.8%$5.33+142.1%+72.2%$176.96M$138.10M4.57170News CoverageSXTCChina SXT Pharmaceuticals0.8559 of 5 stars$1.53-2.2%N/A-80.7%$176.95M$1.93M0.0090Gap UpDERMJourney Medical1.7345 of 5 stars$7.59-1.2%$9.50+25.2%+45.2%$176.85M$56.13M-19.4690News CoverageUpcoming EarningsLIMNLiminatus PharmaN/A$6.72-16.8%N/AN/A$174.79MN/A0.00N/AACRSAclaris Therapeutics2.0224 of 5 stars$1.60-5.1%$8.71+446.4%+27.0%$172.71M$18.72M-1.15100News CoverageEarnings ReportENTAEnanta Pharmaceuticals3.7026 of 5 stars$8.07+0.5%$18.50+129.2%-45.2%$171.92M$67.64M-1.77160 Related Companies and Tools Related Companies CRBU Alternatives ENGN Alternatives VYGR Alternatives CYBN Alternatives CTMX Alternatives SXTC Alternatives DERM Alternatives LIMN Alternatives ACRS Alternatives ENTA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RNXT) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNXT Stock Alerts